RESUMEN
Myxopapillary ependymomas (ME) are considered benign tumours (WHO grade I) of the central nervous system with long term survival rates and a tendency to local recurrence. However an aggressive course has occasionally been described, leading to CSF dissemination and even systemic metastases. We describe the case of a 23-year-old man diagnosed with intracranial subarachnoid dissemination of a filum terminale ME three years after the initial diagnosis. We have performed a careful review of the literature on CSF dissemination in ME and finally propose treatment of these cases.
Asunto(s)
Neoplasias Encefálicas/secundario , Cauda Equina/patología , Ependimoma/secundario , Neoplasias Meníngeas/secundario , Metástasis de la Neoplasia/fisiopatología , Neoplasias de la Médula Espinal/patología , Espacio Subaracnoideo/fisiopatología , Adulto , Neoplasias Encefálicas/radioterapia , Cauda Equina/fisiopatología , Cauda Equina/cirugía , Descompresión Quirúrgica , Progresión de la Enfermedad , Ependimoma/radioterapia , Cefalea/diagnóstico , Cefalea/etiología , Cefalea/fisiopatología , Humanos , Neoplasias Hipotalámicas/radioterapia , Neoplasias Hipotalámicas/secundario , Hipotálamo/patología , Hipotálamo/fisiopatología , Hipotálamo/cirugía , Laminectomía , Dolor de la Región Lumbar/etiología , Dolor de la Región Lumbar/fisiopatología , Dolor de la Región Lumbar/cirugía , Vértebras Lumbares/cirugía , Imagen por Resonancia Magnética , Masculino , Neoplasias Meníngeas/radioterapia , Metástasis de la Neoplasia/diagnóstico , Neurohipófisis/patología , Neurohipófisis/fisiopatología , Neurohipófisis/cirugía , Radioterapia/métodos , Espacio Subaracnoideo/patología , Espacio Subaracnoideo/cirugía , Tercer Ventrículo/patología , Tercer Ventrículo/fisiopatología , Tercer Ventrículo/cirugía , Resultado del TratamientoRESUMEN
Recent advances in immunobiological knowledge have suggested the possibility of enhancing the therapeutic activity of various chemotherapeutic agents by a concomitant administration of anti-oxidant drugs and/or immunomodulating neurohormones. In particular, the pineal neurohormone melatonin (MLT), which is able to exert both antioxidant and immunomodulating effects, has been proven to enhance the efficacy of various chemotherapeutic drugs, namely cisplatin, anthracyclines and 5-fluorouracil, whereas at present there are no data about its possible influence on cytotoxic drugs effective in the treatment of colon cancer other than 5-fluorouracil, such as irinotecan (CPT-11). The present study was performed to evaluate the influence of a concomitant administration of MLT on CPT-11 therapeutic activity in metastatic colorectal cancer. The study included 30 metastatic colorectal cancer patients progressing after at least one previous chemotherapeutic line containing 5-fluorouracil, who were randomized to be treated with CPT-11 alone or CPT-11 plus MLT. According to a weekly low-dose schedule, CPT-11 was given i.v. at 125 mg/m2/week for 9 consecutive weeks. MLT was administered orally at 20 mg/day during the dark period of the day. No complete response was observed. A partial response (PR) was achieved in 2 out of 16 patients treated with CPT-11 alone and in 5 out of 14 patients concomitantly treated with MLT. Moreover, a stable disease (SD) was obtained in 5 out of 16 patients treated with CPT-11 alone and in 7 out of 14 patients treated with CPT-11 plus MLT. Therefore, the percent of disease-control achieved in patients concomitantly treated with MLT was significantly higher than that observed in those treated with chemotherapy alone (12 out of 14 vs 7 out of 16, p < 0.05). The only important toxicity was diarrhoea grade 3-4, which occurred in 6 out of 16 patients treated with CPT-11 alone and in 4 out of 14 patients treated with CPT-11 plus MLT, which required a 50% dose reduction. However, taken together, patients treated with CPT-11 at 50% of the planned dose showed a percent of disease control comparable to that achieved in patients who had no dose reduction (6 out of 10 vs 13 out of 20). This preliminary study shows that the efficacy of weekly low-dose CPT-11 in pretreated metastatic colorectal cancer patients may be enhanced by a concomitant daily administration of the pineal hormone MLT, according to the results previously reported for other chemotherapeutic agents. Moreover, since the dose reduction of CPT-11 does not influence its efficacy, the dose of CPT-11 for successive studies might be not greater than 70 mg/m2.
Asunto(s)
Adyuvantes Inmunológicos/administración & dosificación , Antineoplásicos Fitogénicos/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Camptotecina/análogos & derivados , Camptotecina/uso terapéutico , Neoplasias Colorrectales/tratamiento farmacológico , Melatonina/administración & dosificación , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos Fitogénicos/administración & dosificación , Camptotecina/administración & dosificación , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Sinergismo Farmacológico , Femenino , Humanos , Irinotecán , Masculino , Persona de Mediana EdadRESUMEN
According to recent advances in psychoneuroimmunology concerning the neurobiochemistry of emotions, the pshychological status of cancer patients should be investigated in relation to the function of the psychoneurodocrine system, in an attempt to put into evidence possible cancer progression-related alterations, particularly those involving the dopaminergic pathways, which play a fundamental role in the perception of pleasure. In fact, the decreased capacity of feeling pleasure is one of the most frequent psychic symptoms occurring in cancer patients. Rorschach's test has been proven to be an appropriate psychological tool to investigate psychic condition including sexual and spiritual profiles. On this basis, a study was planned to evaluate if a relation exists between psychological response to Rorschach's test and immunoneuroendocrine status of cancer patients. The immune status was investigated by measuring lymphocyte subsets and serum levels of IL-2 and IL-10. The neuroendocrine status was analyzed by evaluating the endocrine response of PRL, GH and cortisol to an oral administration of apomorphine (0.01 mg/kg b.w.), a dopaminergic agent able to explore dopaminergic sensitivity. The study included 40 cancer patients (breast cancer: 15; colorectal cancer: 14; lung cancer: 11), 21 of whom showed distant organ metastases. Rorschach's test demonstrated a simultaneous suppression of sexual and spiritual profiles in 31/40 (78%) patients, without significant differences in relation to either tumor histotype or disease state. A normal decline in PRL levels and a normal increase in those of GH and cortisol was observed in 29/40 (73%), 5/40 (13%) and 9/40 (23%) patients. The percent of normal responses of PRL, GH and cortisol was higher in patients with normal than in those with altered response to Rorschach's test, even though only the difference in PRL and cortisol response was statistically significant. Patients with normal sexual and spiritual expression at Rorschach's test showed a significantly higher number of total lymphocytes, T lymphocytes, T helper lymphocytes and NK cells with respect to the patients with altered psychological response, whereas no difference was found in T cytotoxic lymphocyte mean number. IL-2 and IL-10 mean serum concentrations were lower and higher, respectively, in patients with altered than in those with normal response to Rorschach's test, even though only the difference in IL-10 values was statitistically significant. This preliminary study, carried out to analyze the psychological status of cancer patients in relation to neuroendocrine and immune conditions, would suggest that neoplastic disease is characterized by a simultaneous suppression of sexual and spiritual profiles, and that this is associated with neuroendocrine alterations and immunosuppression.
Asunto(s)
Emociones , Subgrupos Linfocitarios , Neoplasias/psicología , Sistemas Neurosecretores/efectos de los fármacos , Administración Oral , Adulto , Apomorfina/administración & dosificación , Apomorfina/farmacología , Línea Celular Tumoral , Progresión de la Enfermedad , Agonistas de Dopamina/farmacología , Femenino , Hormona del Crecimiento/farmacología , Humanos , Hidrocortisona/metabolismo , Inmunosupresores , Interleucina-10/sangre , Interleucina-10/metabolismo , Interleucina-2/sangre , Interleucina-2/metabolismo , Células Asesinas Naturales/metabolismo , Linfocitos/metabolismo , Masculino , Persona de Mediana Edad , Prolactina/farmacología , Prueba de Rorschach , Sexualidad , EspiritualidadRESUMEN
Ambasilide, a representative of Class III antiarrhythmics, was reported to prolong the cardiac action potential duration in the dog, with little or no effect on Ca and Na currents. We synthesised a series of ambasilide analogues, having the 3,8-diazabicyclo-[3.2.1]-octane moiety instead of the 3,7-diazabicyclo-[3.3.1]-nonane present in ambasilide. The compounds were tested both in vitro extracellular electrophysiological assays and by the conventional microelectrode technique. Most of them lengthened the effective refractory period (ERP) with no change or slight increase on the impulse conduction time (ICT). Similarly some of the tested compounds lengthened the action potential duration (APD), a typical Class III feature, without exerting any significant effect on the maximal rate of depolarization, therefore apparently lacking Class I antiarrhythmic activity.
Asunto(s)
Aminobenzoatos/química , Aminobenzoatos/farmacología , Antiarrítmicos/química , Antiarrítmicos/síntesis química , Antiarrítmicos/farmacología , Compuestos Bicíclicos Heterocíclicos con Puentes/química , Compuestos Bicíclicos Heterocíclicos con Puentes/farmacología , Ventrículos Cardíacos/efectos de los fármacos , Aminobenzoatos/síntesis química , Animales , Compuestos Bicíclicos Heterocíclicos con Puentes/síntesis química , Perros , Diseño de Fármacos , Técnicas Electrofisiológicas Cardíacas , Femenino , Técnicas In Vitro , Masculino , Microelectrodos , Modelos Moleculares , Conformación Molecular , Relación Estructura-ActividadRESUMEN
This study had two aims: to describe the activities of a clinical training unit set up for the integrated management of sick children, and to evaluate the impact of the unit after its first four years of operation. The training unit was set up in the outpatient ward of a government hospital and was staffed by a paediatrician, a family medicine physician, two nurses and a nutritionist. The staff kept a computerized database for all patients seen and they were supervised once a month. During the first three years, the demand for first-time medical consultation increased by 477% for acute respiratory infections (ARI) and 134% for acute diarrhoea (AD), with an average annual increase of demand for medical care of 125%. Eighty-nine per cent of mothers who took their child for consultation and 85% of mothers who lived in the catchment area and had a deceased child received training on how to recognize alarming signs in a sick child. Fifty-eight per cent of these mothers were evaluated as being properly trained. Eighty-five per cent of primary care physicians who worked for government institutions (n = 350) and 45% of private physicians (n = 90) were also trained in the recognition and proper management of AD and ARI. ARI mortality in children under 1 year of age in the catchment area (which included about 25,000 children under 5 years of age) decreased by 43.2% in three years, while mortality in children under 5 years of age decreased by 38.8%. The corresponding figures for AD mortality reduction were 36.3% and 33.6%. In this same period, 11 clinical research protocols were written. In summary, we learned that a clinical training unit for integrated child care management was an excellent way to offer in-service training for primary health care physicians.
Asunto(s)
Servicios de Salud del Niño/organización & administración , Prestación Integrada de Atención de Salud/organización & administración , Educación Médica Continua/organización & administración , Niño , Hospitales Públicos , Humanos , México , Modelos Educacionales , Servicio Ambulatorio en Hospital , Evaluación de Programas y Proyectos de SaludRESUMEN
Three different blood units were treated separately by the hypotonic dialysis (HD) and the dimethylsulphoxide osmotic pulse (DMSO) method, in order to load the erythrocytes with inositol hexaphosphate. A detailed comparison between the two loading techniques was performed by monitoring the red cell distribution patterns on discontinuous Percoll density gradients, the RBC oxygen affinity and the amount of the main intracellular organic phosphates with the 31P-NMR. The results obtained showed that: (1) The HD loading produces a redistribution of the RBC fractions with a concomitant smoothing of the relative differences among distinct fractions (2) only a minor portion of erythrocytes (from 8.5 to 24.9% of total RBCs) are loaded with IHP after the DMSO treatment. All of these cells move to the lightest fraction (d = 1.080 g/ml). (3) Both HD and DMSO IHP-loaded cells show an increase in P50 (basal vs. after loading, means +/- SD: 25.8 +/- 3.0 vs. 52.5 +/- 3.2 mm Hg) correlated to the IHP incorporation (mean intracellular IHP concentration: 4.2 mmol/l RBC). (4) probably the IHP incorporation efficiency could be probably improved at least by increasing the IHP concentration during the treatment.
Asunto(s)
Diálisis , Dimetilsulfóxido , Membrana Eritrocítica , Soluciones Hipotónicas , Ácido Fítico/sangre , Pruebas Hematológicas , Humanos , Espectroscopía de Resonancia Magnética , Compuestos Organofosforados/sangre , Presión Osmótica , Oxígeno/sangre , Fósforo , VolumetríaAsunto(s)
Trasplante de Médula Ósea/inmunología , Inmunotoxinas/uso terapéutico , Lectinas/uso terapéutico , Depleción Linfocítica , Ricina/uso terapéutico , Proteínas de Soja , Linfocitos T/inmunología , Anticuerpos Monoclonales/uso terapéutico , Trasplante de Médula Ósea/métodos , Humanos , Lectinas de Plantas , Glycine maxRESUMEN
Arachidonate induces aggregation of human polymorphonuclear (PMN) and mononuclear (MNL) blood leukocytes. This is mediated by the lipoxygenase pathway, as it is prevented by lipoxygenase inhibitors and can also be induced by leukotriene B4 (LTB4). Vitamin E and vitamin C have profound effects on the functional state of leukocytes, some of which may involve the lipoxygenase pathway. This study shows that both vitamins inhibit arachidonate-induced aggregation of PMN and MNL, in a concentration-dependent way. BW-755, previously shown to inhibit arachidonate-induced PMN and NML aggregation, was found to potentiate the inhibitory activity of both vitamins. When LTB4 was used as an aggregating agent, vitamin E markedly inhibited PMN and MNL aggregation, whereas vitamin C was ineffective. The prevention of PMN and MNL aggregation by vitamin E might account, at least partially, for the reported beneficial effects of vitamin E supplementation in some experimental syndromes characterized by leukocyte activation.